Elevated calcitonin and carcino-embryonic antigen levels are the most significant clinical features of MTC; hence, calcitonin is used as a sensitive biochemical marker of MTC [13]. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.